$110.92+32.31% · 3M
Moving avg
1W+4.92%
1M+20.42%
3M+32.31%
6M-2.35%
YTD-10.69%
1Y-15.34%
3Y+4.54%
5Y-9.69%
52-week range
$81.9752% of range$137.49
Company health
Value1/6
Growth3/6
Profitability5/6
Health5/6
Dividend3/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (1055%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$191.93B
Enterprise value
$206.82B
P/E ratio (TTM)
33.15x
P/S ratio (TTM)
3.85x
EV/EBITDA
20.80x
Per share & returns
EPS (TTM)
$3.11
Dividend yield
2.41%
Beta (1Y)
0.61
30-day change
+20.42%
Trading
Volume (24h)
5.28M
Previous close
$109.72
Shares outstanding
1.73B
About Abbott Laboratories
Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE
Symbol
ABT
Abbott Laboratories is a large-cap healthcare company in the Medical - Devices industry. Its shares are listed on NYSE (United States) and trade under the ticker ABT.
Frequently asked questions
What is Abbott Laboratories's market cap?
Abbott Laboratories (ABT) has a market capitalization of $191.93B.
What is Abbott Laboratories's P/E ratio?
Abbott Laboratories trades at a price-to-earnings (P/E) ratio of 33.15.
What exchange does ABT trade on?
ABT trades on NYSE.
Appears in
Compare & explore
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.92B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.41B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap